Malignant primary tumours of the liver other than hepatocellular carcinoma;Tumeurs hépatiques malignes primitives en dehors du carcinome hépatocellulaire

EMC - Hepato-Gastroenterologie

Volumn 2, Issue 1, 2005, Pages 19-27

  Cholet, F ^a   Nousbaum, J B ^a   Lagarde, N ^b   Turlin, B ^c  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Liver; Malignant tumours

Indexed keywords

EID: 32544440167     PISSN: 17696763     EISSN: 17696763     Source Type: Journal    
DOI: 10.1016/j.emchg.2004.12.003     Document Type: Short Survey

References (43)

1. Anderson BB, Ukah F, Tette A, Villaflor SG, Koh D, Seton P. Primary tumors of the liver. J Natl Med Assoc 1992;84:129-35.
2. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002;37:806-13.
3. Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995;117:146-55.
4. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-35.
5. Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, et al. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 2001;76:29-33.
6. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
7. Nakajima T, Tajima Y, Sugano I, Nagao K, Kondo Y, Wada K. Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases. Cancer 1993;72:1872-7.
8. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985;55:124-35.
9. Papotti M, Sambataro D, Marchesa P, Negro F. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features. Liver 1997;17:47-52.
10. De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-16.
11. Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815-22.
12. Mezawa S, Homma H, Sato T, Doi T, Miyanishi K, Takada K, et al. A study of carboplatin-coated tube for the unresectable cholangiocarcinoma. Hepatotogy 2000;32:916-23.
13. Buetow PC, Buck JL, Pantongrag-Brown L, Ros PR, Devaney K, Goodman ZD, et al. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995;196:805-10.
14. Wang YJ, Lee SD, Lai KH, Wang SS, Lo KJ. Primary biliary cystic tumors of the liver. Am J Gastroenterol 1993;88: 599-603.
15. Korobkin M, Stephens DH, Lee JK, Stanley RJ, Fishman EK, Francis IR, et al. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol 1989;153:507-11.
16. Vuillemin-Bodaghi V, Zins M, Vullierme MP, Denys A, Sibert A, Vilgrain V, et al Imagerie des kystes atypiques du foie. Étude de 26 lésions opérées. Gastroentérol Clin Biol 1997;21:394-9.
17. Tresallet C, Jordi-Galais P, Nguyen-Thanh Q, Aubriot-Lorton MH, Costedoat-Chalumeau N, Chigot JP, et al. Cystadenoma of the liver with high levels of ACE and CA 19-9 in the cyst. Gastroentérol Clin Biol 2003;27:413-5.
18. Owono P, Scoazec JY, Valette PJ, Dumortier J, Gouysse G, Berger F, et al. Cystadénomes et cystadénocarcinomes hépatobiliaires. Étude clinique, radiologique et anatomopathologique de 7 cas. Gastroentérol Clin Biol 2001;25: 414-21.
19. Cadranel JF, Vilgrain V, Flejou JF, Boillot O, Marmuse JP, Duron JJ, et al. Cystadénome du foie. Étude clinique, radiologique et anatomopathologique de 5 cas, dont un associé à un cystadénocarcinome. Gastroentérol Clin Biol 1994;18:84-9.
20. Zafrani ES. Update on vascular tumours of the liver. J Hepatol 1989;8:125-30.
21. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine 1979;58:48-64.
22. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 2003;48:677-82.
23. Koyama T, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology 2002;222:667-73.
24. Neshiwat LF, Friedland ML, Schorr-Lesnick B, Feldman S, Glucksman WJ, Russo Jr. RD. Hepatic angiosarcoma. Am J Med 1992;93:219-22.
25. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999;85:562-82.
26. Peterson MS, Murakami T, Baron RL. MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging 1998;23:592-9.
27. Soslow RA, Yin P, Steinberg CR, Yang GC. Cytopathologic features of hepatic epithelioid hemangioendothelioma. Diagn Cytopathol 1997;17:50-3.
28. Scoazec JY, Lamy P, Degott C, Reynes M, Feldmann G, Bismuth H, et al. Epithelioid hemangioendothelioma of the liver. Diagnostic features and role of liver transplantation. Gastroenterology 1988;94:1447-53.
29. Idilman R, Dokmeci A, Beyler AR, Bastemir M, Ormeci N, Aras N, et al. Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology 1997;54:171-5.
30. Babin-Boilletot A, Flamant F, Terrier-Lacombe MJ, Marsden HB, Van Unnik A, Demeocq F, et al. Primitive malignant nonepithelial hepatic tumors in children. Med Pediatr Oncol 1993;21:634-9.
31. Reynolds M. Pediatric liver tumors. Cancer Treat Res 2001; 109:299-312.
32. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol 1983;14:512-37.
33. Conran RM, Hitchcock CL, Waclawiw MA, Stocker JT, Ishak KG. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 1992;12:167-83.
34. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 2000;1:94-100.
35. Stringer MD, Hennayake S, Howard ER, Spitz L, Shafford EA, Mieli-Vergani G, et al. Improved outcome for children with hepatoblastoma. Br J Surg 1995;82:386-91.
36. Zafrani ES, Gaulard P. Primary lymphoma of the liver. Liver 1993;13:57-61.
37. Brugière O, Pialoux G, Carnot F, Pol S, Fournier S, Deslandes P, et al. Lymphomes non hodgkiniens primitifs du foie chez les malades infectés par le virus de l'immunodéficience humaine. Trois cas. Gastroentérol Clin Biol 1996; 20:307-11.
38. Andres E, Herbrecht R, Campos F, Marcellin L, Oberling F. Primary hepatic lymphoma associated with chronic hepatitis C. Ann Méd Interne 1997;148:280-3.
39. Golli L, Taieb J, Boleslawski E, Charlotte F, Taboury J, Di Martino V, et al. Lymphome du MALT hépatique de bas grade de malignité associé à une cirrhose biliaire primitive. Gastroentérol Clin Biol 2003;27:127-9.
40. Leblond V, Choquet S. Lymphoproliferative disorders after liver transplantation. J Hepatol 2004;40:728-35.
41. Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001;7:746-50.
42. Pilichowska M, Kimura N, Ouchi A, Lin H, Mizuno Y, Nagura H. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int 1999;49:318-24.
43. Maire F, Couvelard A, Kianmanesh R, O'Toole D, Vuillerme MP, Aubert A, et al. Caractéristiques et pronostic des tumeurs endocrines primitives du foie. Gastroentérol Clin Biol 2003;27:A140 Hors série I.